gene_id,gene_symbol,name,in_manning,in_kinmap,in_uniprot_kinasedomain,in_IDG_darkkinases,n_pubmed_citations_2013to2018,pharos_designation,PDB,title,expMethod,deposition_date,last_modification_date,resolution,InChI,InChIKey,chemicalName,smiles,formula,molecularWeight
1459,CSNK2A2,casein kinase 2 alpha 2,1,1,1,1,12,Tchem,5YF9,Crystal structure of CK2a2 form-2,X-RAY DIFFRACTION,2017-09-20,2018-05-16,1.89,"InChI=1S/C6H5NO2/c8-6(9)5-2-1-3-7-4-5/h1-4H,(H,8,9);InChI=1S/H2O4S/c1-5(2,3)4/h(H2,1,2,3,4)/p-2",PVNIIMVLHYAWGP-UHFFFAOYSA-N;QAOWNCQODCNURD-UHFFFAOYSA-L,NICOTINIC ACID;SULFATE ION,c1cc(cnc1)C(=O)O;[O-]S(=O)(=O)[O-],C6 H5 N O2;O4 S -2,123.109;96.063
1459,CSNK2A2,casein kinase 2 alpha 2,1,1,1,1,12,Tchem,3OFM,"Structure of a human CK2alpha prime, the paralog isoform of the catalytic subunit of protein kinase CK2 from Homo sapiens",X-RAY DIFFRACTION,2010-08-15,2013-06-19,2,"InChI=1S/C9H7Br4N3O/c10-4-5(11)7(13)9-8(6(4)12)14-15-16(9)2-1-3-17/h17H,1-3H2;InChI=1S/ClH/h1H/p-1",VXLNELSTYPRMEW-UHFFFAOYSA-N;VEXZGXHMUGYJMC-UHFFFAOYSA-M,"3-(4,5,6,7-tetrabromo-1H-benzotriazol-1-yl)propan-1-ol;CHLORIDE ION",C(Cn1c2c(c(c(c(c2Br)Br)Br)Br)nn1)CO;[Cl-],C9 H7 Br4 N3 O;Cl -1,492.787;35.453
1459,CSNK2A2,casein kinase 2 alpha 2,1,1,1,1,12,Tchem,5YWM,Crystal structure of CK2a2 form-1,X-RAY DIFFRACTION,2017-11-29,2018-12-05,1.94,"InChI=1S/C6H5NO2/c8-6(9)5-2-1-3-7-4-5/h1-4H,(H,8,9);InChI=1S/H2O4S/c1-5(2,3)4/h(H2,1,2,3,4)/p-2",PVNIIMVLHYAWGP-UHFFFAOYSA-N;QAOWNCQODCNURD-UHFFFAOYSA-L,NICOTINIC ACID;SULFATE ION,c1cc(cnc1)C(=O)O;[O-]S(=O)(=O)[O-],C6 H5 N O2;O4 S -2,123.109;96.063
1459,CSNK2A2,casein kinase 2 alpha 2,1,1,1,1,12,Tchem,5Y9M,Crystal structure of CK2a2 form 3,X-RAY DIFFRACTION,2017-08-25,2018-05-16,2.01,"InChI=1S/C6H5NO2/c8-6(9)5-2-1-3-7-4-5/h1-4H,(H,8,9);InChI=1S/H2O4S/c1-5(2,3)4/h(H2,1,2,3,4)/p-2",PVNIIMVLHYAWGP-UHFFFAOYSA-N;QAOWNCQODCNURD-UHFFFAOYSA-L,NICOTINIC ACID;SULFATE ION,c1cc(cnc1)C(=O)O;[O-]S(=O)(=O)[O-],C6 H5 N O2;O4 S -2,123.109;96.063
1459,CSNK2A2,casein kinase 2 alpha 2,1,1,1,1,12,Tchem,5OOI,STRUCTURE OF PROTEIN KINASE CK2 CATALYTIC SUBUNIT (ISOFORM CK2ALPHA') IN COMPLEX WITH THE INDENOINDOLE-TYPE INHIBITOR 4P,X-RAY DIFFRACTION,2017-08-07,2018-10-10,2,"InChI=1S/C23H25NO3/c1-13(2)11-12-27-18-10-5-7-15-19(18)22-21(23(15)26)20-16(24(22)14(3)4)8-6-9-17(20)25/h5,7,10-11,14H,6,8-9,12H2,1-4H3;InChI=1S/C2H4O2/c1-2(3)4/h1H3,(H,3,4)/p-1;InChI=1S/C2H6O2/c3-1-2-4/h3-4H,1-2H2;InChI=1S/Na/q+1",IGWUYWFNHIJBBD-UHFFFAOYSA-N;QTBSBXVTEAMEQO-UHFFFAOYSA-M;LYCAIKOWRPUZTN-UHFFFAOYSA-N;FKNQFGJONOIPTF-UHFFFAOYSA-N,"4-(3-methylbut-2-enoxy)-5-propan-2-yl-7,8-dihydro-6~{H}-indeno[1,2-b]indole-9,10-dione;ACETATE ION;1,2-ETHANEDIOL;SODIUM ION",CC(C)n1c2c(c3c1-c4c(cccc4OCC=C(C)C)C3=O)C(=O)CCC2;CC(=O)[O-];C(CO)O;[Na+],C23 H25 N O3;C2 H3 O2 -1;C2 H6 O2;Na 1,363.45;59.044;62.068;22.99
1459,CSNK2A2,casein kinase 2 alpha 2,1,1,1,1,12,Tchem,3E3B,Crystal structure of catalytic subunit of human protein kinase CK2alpha prime with a potent indazole-derivative inhibitor,X-RAY DIFFRACTION,2008-08-07,2011-07-13,3.2,"InChI=1S/C20H20N6O2/c1-13(2)23-16-4-3-15-9-22-26(17(15)8-16)19-11-21-10-18(24-19)25-6-5-14(12-25)7-20(27)28/h3-6,8-13,23H,7H2,1-2H3,(H,27,28)",BBYRUZKRFAIQSR-UHFFFAOYSA-N,[1-(6-{6-[(1-methylethyl)amino]-1H-indazol-1-yl}pyrazin-2-yl)-1H-pyrrol-3-yl]acetic acid,CC(C)Nc1ccc2cnn(c2c1)c3cncc(n3)n4ccc(c4)CC(=O)O,C20 H20 N6 O2,376.412
1459,CSNK2A2,casein kinase 2 alpha 2,1,1,1,1,12,Tchem,5M4U,"ORTHORHOMBIC COMPLEX STRUCTURE OF HUMAN PROTEIN KINASE CK2 CATALYTIC SUBUNIT (ISOFORM CK2ALPHA') WITH THE INHIBITOR 4'-CARBOXY-6,8-CHLORO- FLAVONOL (FLC21)",X-RAY DIFFRACTION,2016-10-19,2018-10-10,2.19,"InChI=1S/C16H8Cl2O5/c17-9-5-10-12(19)13(20)14(23-15(10)11(18)6-9)7-1-3-8(4-2-7)16(21)22/h1-6,20H,(H,21,22);InChI=1S/C2H4O2/c1-2(3)4/h1H3,(H,3,4)/p-1;InChI=1S/ClH/h1H/p-1;InChI=1S/C3H8O3/c4-1-3(6)2-5/h3-6H,1-2H2;InChI=1S/H2O4S/c1-5(2,3)4/h(H2,1,2,3,4)/p-2",CFWCAEJMOUILDR-UHFFFAOYSA-N;QTBSBXVTEAMEQO-UHFFFAOYSA-M;VEXZGXHMUGYJMC-UHFFFAOYSA-M;PEDCQBHIVMGVHV-UHFFFAOYSA-N;QAOWNCQODCNURD-UHFFFAOYSA-L,"4-[6,8-bis(chloranyl)-3-oxidanyl-4-oxidanylidene-chromen-2-yl]benzoic acid;ACETATE ION;CHLORIDE ION;GLYCEROL;SULFATE ION",c1cc(ccc1C2=C(C(=O)c3cc(cc(c3O2)Cl)Cl)O)C(=O)O;CC(=O)[O-];[Cl-];C(C(CO)O)O;[O-]S(=O)(=O)[O-],C16 H8 Cl2 O5;C2 H3 O2 -1;Cl -1;C3 H8 O3;O4 S -2,351.138;59.044;35.453;92.094;96.063
1459,CSNK2A2,casein kinase 2 alpha 2,1,1,1,1,12,Tchem,5M56,"Monoclinic complex structure of human protein kinase CK2 catalytic subunit (isoform CK2alpha') with the inhibitor 4'-carboxy-6,8-chloro-flavonol (FLC21)",X-RAY DIFFRACTION,2016-10-20,2018-10-10,2.24,"InChI=1S/C16H8Cl2O5/c17-9-5-10-12(19)13(20)14(23-15(10)11(18)6-9)7-1-3-8(4-2-7)16(21)22/h1-6,20H,(H,21,22);InChI=1S/ClH/h1H/p-1;InChI=1S/C3H8O3/c4-1-3(6)2-5/h3-6H,1-2H2",CFWCAEJMOUILDR-UHFFFAOYSA-N;VEXZGXHMUGYJMC-UHFFFAOYSA-M;PEDCQBHIVMGVHV-UHFFFAOYSA-N,"4-[6,8-bis(chloranyl)-3-oxidanyl-4-oxidanylidene-chromen-2-yl]benzoic acid;CHLORIDE ION;GLYCEROL",c1cc(ccc1C2=C(C(=O)c3cc(cc(c3O2)Cl)Cl)O)C(=O)O;[Cl-];C(C(CO)O)O,C16 H8 Cl2 O5;Cl -1;C3 H8 O3,351.138;35.453;92.094
